Psychopharmacology of chronic pain

Research output: Contribution to journalArticle

Abstract

Chronic pain is a common problem. Neuropathic pain, ranging from diabetic peripheral neuropathy and postherpetic neuralgia to less well understood conditions such as fibromyalgia, affects approximately 3% of the world's population. The pathophysiology of these disorders, such as ion channel upregulation, spinal hyperexcitability, and descending facilitation, has been detailed through extensive research. Psychotropics such as antidepressants, anticonvulsants, and neuroleptics offer effective alternatives to conventional analgesics. Antidepressants typically block the reuptake of monoamines such as norepinephrine and serotonin. Increased amounts of these neurotransmitters are presumed to increase descending inhibition of nociception. Anticonvulsants possess more heterogeneity in their pharmacology. Many anticonvulsants block use-dependent sodium channels that are increased in number on damaged neurons. Other anticonvulsants modulate calcium channels required for the release of neurotransmitters at the synaptic cleft. Newer anticonvulsants affect other nociceptive components such as the γ-aminobutyric acid receptor complex, N-methyl-D-aspartate receptors, and protect neurons from free radical damage. Atypical neuroleptics can augment other medications through their actions at dopamine and serotonin receptors that likely interact with the opioid- and adreno-receptor systems. Benzodiazepines, while widely prescribed, generally cause more problems, such as cognitive impairment and physicial dependence, than benefits. However, significant pain relief can be achieved in a select group of patients.

Original languageEnglish (US)
Pages (from-to)70-79
Number of pages10
JournalPrimary Psychiatry
Volume14
Issue number9
StatePublished - Sep 2007

Fingerprint

Psychopharmacology
Chronic Pain
Anticonvulsants
Antidepressive Agents
Antipsychotic Agents
Neurotransmitter Agents
Postherpetic Neuralgia
Aminobutyrates
Neurons
Nociception
Fibromyalgia
Diabetic Neuropathies
Sodium Channels
Serotonin Receptors
Dopamine Receptors
Opioid Receptors
Neuralgia
Peripheral Nervous System Diseases
Calcium Channels
N-Methyl-D-Aspartate Receptors

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Genetics

Cite this

Psychopharmacology of chronic pain. / Clark, Michael.

In: Primary Psychiatry, Vol. 14, No. 9, 09.2007, p. 70-79.

Research output: Contribution to journalArticle

Clark, Michael. / Psychopharmacology of chronic pain. In: Primary Psychiatry. 2007 ; Vol. 14, No. 9. pp. 70-79.
@article{1101ee90064b46b48a0f507a4354ba16,
title = "Psychopharmacology of chronic pain",
abstract = "Chronic pain is a common problem. Neuropathic pain, ranging from diabetic peripheral neuropathy and postherpetic neuralgia to less well understood conditions such as fibromyalgia, affects approximately 3{\%} of the world's population. The pathophysiology of these disorders, such as ion channel upregulation, spinal hyperexcitability, and descending facilitation, has been detailed through extensive research. Psychotropics such as antidepressants, anticonvulsants, and neuroleptics offer effective alternatives to conventional analgesics. Antidepressants typically block the reuptake of monoamines such as norepinephrine and serotonin. Increased amounts of these neurotransmitters are presumed to increase descending inhibition of nociception. Anticonvulsants possess more heterogeneity in their pharmacology. Many anticonvulsants block use-dependent sodium channels that are increased in number on damaged neurons. Other anticonvulsants modulate calcium channels required for the release of neurotransmitters at the synaptic cleft. Newer anticonvulsants affect other nociceptive components such as the γ-aminobutyric acid receptor complex, N-methyl-D-aspartate receptors, and protect neurons from free radical damage. Atypical neuroleptics can augment other medications through their actions at dopamine and serotonin receptors that likely interact with the opioid- and adreno-receptor systems. Benzodiazepines, while widely prescribed, generally cause more problems, such as cognitive impairment and physicial dependence, than benefits. However, significant pain relief can be achieved in a select group of patients.",
author = "Michael Clark",
year = "2007",
month = "9",
language = "English (US)",
volume = "14",
pages = "70--79",
journal = "Primary Psychiatry",
issn = "1082-6319",
publisher = "MBL Communications",
number = "9",

}

TY - JOUR

T1 - Psychopharmacology of chronic pain

AU - Clark, Michael

PY - 2007/9

Y1 - 2007/9

N2 - Chronic pain is a common problem. Neuropathic pain, ranging from diabetic peripheral neuropathy and postherpetic neuralgia to less well understood conditions such as fibromyalgia, affects approximately 3% of the world's population. The pathophysiology of these disorders, such as ion channel upregulation, spinal hyperexcitability, and descending facilitation, has been detailed through extensive research. Psychotropics such as antidepressants, anticonvulsants, and neuroleptics offer effective alternatives to conventional analgesics. Antidepressants typically block the reuptake of monoamines such as norepinephrine and serotonin. Increased amounts of these neurotransmitters are presumed to increase descending inhibition of nociception. Anticonvulsants possess more heterogeneity in their pharmacology. Many anticonvulsants block use-dependent sodium channels that are increased in number on damaged neurons. Other anticonvulsants modulate calcium channels required for the release of neurotransmitters at the synaptic cleft. Newer anticonvulsants affect other nociceptive components such as the γ-aminobutyric acid receptor complex, N-methyl-D-aspartate receptors, and protect neurons from free radical damage. Atypical neuroleptics can augment other medications through their actions at dopamine and serotonin receptors that likely interact with the opioid- and adreno-receptor systems. Benzodiazepines, while widely prescribed, generally cause more problems, such as cognitive impairment and physicial dependence, than benefits. However, significant pain relief can be achieved in a select group of patients.

AB - Chronic pain is a common problem. Neuropathic pain, ranging from diabetic peripheral neuropathy and postherpetic neuralgia to less well understood conditions such as fibromyalgia, affects approximately 3% of the world's population. The pathophysiology of these disorders, such as ion channel upregulation, spinal hyperexcitability, and descending facilitation, has been detailed through extensive research. Psychotropics such as antidepressants, anticonvulsants, and neuroleptics offer effective alternatives to conventional analgesics. Antidepressants typically block the reuptake of monoamines such as norepinephrine and serotonin. Increased amounts of these neurotransmitters are presumed to increase descending inhibition of nociception. Anticonvulsants possess more heterogeneity in their pharmacology. Many anticonvulsants block use-dependent sodium channels that are increased in number on damaged neurons. Other anticonvulsants modulate calcium channels required for the release of neurotransmitters at the synaptic cleft. Newer anticonvulsants affect other nociceptive components such as the γ-aminobutyric acid receptor complex, N-methyl-D-aspartate receptors, and protect neurons from free radical damage. Atypical neuroleptics can augment other medications through their actions at dopamine and serotonin receptors that likely interact with the opioid- and adreno-receptor systems. Benzodiazepines, while widely prescribed, generally cause more problems, such as cognitive impairment and physicial dependence, than benefits. However, significant pain relief can be achieved in a select group of patients.

UR - http://www.scopus.com/inward/record.url?scp=34848869639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848869639&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34848869639

VL - 14

SP - 70

EP - 79

JO - Primary Psychiatry

JF - Primary Psychiatry

SN - 1082-6319

IS - 9

ER -